NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

Cryoport may be behind the UK Property Transaction. Today they announced a significant financing from Petrichor Healthcare Capital Management.

https://www.prnewswire.com/news-releases/cryoport-announces-25-million-investment-from-petrichor-healthcare-capital-management-300767257.html

Cryoport provides cryogenic logistic services for Novartis and Gilead for their CAR-T therapies, and has logistics depots next to both of their manufacturing facilities. Cryoport provided logistics services for Northwest Biotherapeutics during their trial and would require a significant amount of warehouse space for commercial production, and would begin preparations well in advance. As I noted on a post on the CYRX board, “Sir Bruce Keogh, is a member of Petrichor's Advisory Board and recent appointee to the Board of Directors of UK-based non-profit Cell and Gene Therapy (CGT) Catapult.”

https://petrichorcap.com
What We Do
Petrichor makes structured equity and credit investments across the global healthcare sector, with a focus on Biopharmaceuticals, Medical Technology, and Diagnostics. We provide flexible and tailored investment solutions for late and commercial stage companies. We work with both public and private companies to support their long-term growth efforts and have experience underwriting product acquisitions, product development activities, and commercial launches or expansions, among other types of situations. Our investment structures are designed to provide capital solutions that enable leading healthcare innovators to reach the next stage of their evolution. Petrichor acts as a strategic advisor, partnering with management, Boards of Directors, and other investors to help ensure the success of our companies.